Portage Biotech (Portage Biotech) Other Long Term Assets : $0.50 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Portage Biotech Other Long Term Assets?

Portage Biotech's other long-term assets for the quarter that ended in Dec. 2023 was $0.50 Mil.

Portage Biotech's quarterly other long-term assets declined from Jun. 2023 ($0.89 Mil) to Sep. 2023 ($0.89 Mil) but then stayed the same from Sep. 2023 ($0.89 Mil) to Dec. 2023 ($0.50 Mil).

Portage Biotech's annual other long-term assets declined from Mar. 2021 ($0.06 Mil) to Mar. 2022 ($0.04 Mil) but then increased from Mar. 2022 ($0.04 Mil) to Mar. 2023 ($0.88 Mil).

Portage Biotech Other Long Term Assets Historical Data

The historical data trend for Portage Biotech's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Other Long Term Assets Chart

Portage Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Long Term Assets

Get a 7-Day Free Trial

0.05

0.03

0.06

0.04

0.88

Portage Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															0.93	0.88	0.89	0.89	0.50

Portage Biotech Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Portage Biotech (Portage Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110

Website

https://www.portagebiotech.com

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.